{"url_path":"/sec/xtnt/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 **","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1453593/0001493152-26-022604-index.html","accession_number":"0001493152-26-022604","cik":"0001453593","ticker":"XTNT","issuer_name":"Xtant Medical Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1453593/0001493152-26-022604-index.html","primary_entity_key":"0001453593","primary_entity_name":"Xtant Medical Holdings, Inc."},"word_count":737,"has_tables":true,"body_markdown":"**ITEM\n6.**\n**Exhibits**\n\n \n\nThe\nfollowing exhibits are being filed or furnished with this Quarterly Report on Form 10-Q:\n\n \n\n**Exhibit\nNo.**\n \n**Description**\n\n2.1†\n \n[Asset Purchase Agreement, dated July 7, 2025, among Xtant Medical Holdings, Inc., Surgalign SPV, Inc., and Companion Spine, LLC, or its Affiliate designee (filed as Exhibit 2.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on July 8, 2025 (SEC File No. 001-34951) and incorporated by reference herein)](https://www.sec.gov/Archives/edgar/data/1453593/000164117225018092/ex2-1.htm)\n\n \n \n \n\n2.2†\n \n[Amendment to Asset Purchase Agreement, dated as November 30, 2025, between Xtant Medical Holdings, Inc., Surgalign SPV, Inc., and Companion Spine, LLC or its Affiliate designee (filed as Exhibit 2.3 to the Registrant’s Current Report on Form 8-K filed with the SEC on December 3, 2025 (SEC File No. 001-34951) and incorporated by reference herein)](https://www.sec.gov/Archives/edgar/data/1453593/000149315225025963/ex2-3.htm)\n\n \n \n \n\n2.3†\n \n[Equity Purchase Agreement, dated July 7, 2025, among Xtant Medical Holdings, Inc., Paradigm Spine GmbH, and Companion Spine, LLC (filed as Exhibit 2.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on July 8, 2025 (SEC File No. 001-34951) and incorporated by reference herein)](https://www.sec.gov/Archives/edgar/data/1453593/000164117225018092/ex2-2.htm)\n\n \n \n \n\n2.4\n \n[Amendment to and Assignment of Equity Purchase Agreement, dated November 30, 2025, among Xtant Medical Holdings, Inc., Paradigm Spine GmbH, Companion Spine, LLC and Companion Spine France SAS (filed as Exhibit 2.4 to the Registrant’s Current Report on Form 8-K filed with the SEC on December 3, 2025 (SEC File No. 001-34951) and incorporated by reference herein)](https://www.sec.gov/Archives/edgar/data/1453593/000149315225025963/ex2-4.htm)\n\n \n \n \n\n2.5\n \n[Second Amendment to Equity Purchase Agreement, dated January 14, 2026, between Xtant Medical Holdings, Inc. and Companion Spine France SAS (filed herewith)](ex2-5.htm)\n\n \n \n \n\n3.1\n \n[Restated Certificate of Incorporation of Xtant Medical Holdings, Inc. (filed as Exhibit 3.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 (SEC File No. 001-34951) and incorporated by reference herein).](https://www.sec.gov/Archives/edgar/data/1453593/000149315223041077/ex3-1.htm)\n\n \n \n \n\n3.2\n \n[Third Amended and Restated Bylaws of Xtant Medical Holdings, Inc. (Effective as of June 1, 2023) (filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on May 19, 2023 (SEC File No. 001-34951) and incorporated by reference herein).](https://www.sec.gov/Archives/edgar/data/1453593/000149315223018330/ex3-1.htm)\n\n \n \n \n\n10.1\n \n[Amendment No. 4 to Amended and Restated Credit, Security and Guaranty Agreement (Term Loan), dated as of March 26, 2026, among Xtant Medical, Inc., Bacterin International, Inc., X-spine Systems, Inc., Surgalign SPV, Inc., and any additional borrower that hereafter becomes party thereto, Xtant Medical Holdings, Inc., as a guarantor, MidCap Financial Trust, as agent, and the other financial institutions or other entities from time to time parties thereto (filed as Exhibit 10.42 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2025 (SEC File No. 001-34951) and incorporated by reference herein)](https://www.sec.gov/Archives/edgar/data/1453593/000149315226013792/ex10-42.htm)\n\n \n \n \n\n10.2\n \n[Amendment No. 4 to Amended and Restated Credit, Security and Guaranty Agreement (Revolving Loan), dated as of March 26, 2026, among Xtant Medical, Inc., Bacterin International, Inc., X-spine Systems, Inc., Surgalign SPV, Inc., and any additional borrower that hereafter becomes party thereto, Xtant Medical Holdings, Inc., as a guarantor, MidCap Funding IV Trust, as agent, and the other financial institutions or other entities from time to time parties thereto (filed as Exhibit 10.43 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2025 (SEC File No. 001-34951) and incorporated by reference herein)](https://www.sec.gov/Archives/edgar/data/1453593/000149315226013792/ex10-43.htm)\n\n \n \n \n\n31.1\n \n[Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).](ex31-1.htm)\n\n \n \n \n\n31.2\n \n[Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).](ex31-2.htm)\n\n \n \n \n\n32.1\n \n[Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).](ex32-1.htm)\n\n \n \n \n\n32.2\n \n[Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).](ex32-2.htm)\n\n \n \n \n\n101\n \nThe\nfollowing materials from Xtant’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026, formatted in Inline\nXBRL (Extensible Business Reporting Language): (i) the unaudited Condensed Consolidated Balance Sheets, (ii) the unaudited Condensed\nConsolidated Statements of Operations, (iii) the unaudited Condensed Consolidated Statements of Equity, (iv) the unaudited Condensed\nConsolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements (filed herewith).\n\n \n \n \n\n104\n \nCover\nPage Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n \n\n†All exhibits and schedules to this exhibit have been omitted pursuant to"}